Valeant Eyeing Dermatology, Dentistry for M&A: CEO

March 19 (Bloomberg) -- Mike Pearson, chief executive officer of Valeant Pharmaceuticals International Inc., talks about the company's acquisition and growth strategy. He speaks with Stephanie Ruhle and Matt Miller on Bloomberg Television's "Market Makers." (Source: Bloomberg)
A ‘No’ Vote Doesn’t Mean a ‘Grexit’: Saywell
44:07 - BNP Paribas Global Head of FX Strategy Steven Saywell discusses the Greek referendum and its impact on the markets. He speaks to Bloomberg’s Anna Edwards on “Countdown.” (Source: Bloomberg)
  • Greeks Split Down Middle Before Referendum
  • Greeks Split Evenly on Austerity: Bloomberg Poll
  • EU Creditors Won't Wave Wand on Greek Debt: Brown